Rapid growth is one characteristic of pancreatic cancer. Our data indicates that the TRAF2/NIK/NF-κB2 pathway regulates PDAC cell tumorigenicity and could be a valuable target for therapy of this cancer.
No takes yet. Share an insight, caveat, or question.
Döppler et al. (2013) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: